SYN-010 21 mg

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Irritable Bowel Syndrome With Constipation (IBS-C)

Drug Information

Target Indication

Irritable Bowel Syndrome With Constipation (IBS-C)

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

TOVX

Theriva Biologics, Inc.

Related Pipeline

Healthy Volunteers

Healthy Volunteers With Ileostomy

Irritable Bowel Syndrome With Constipation (IBS-C)